ÂÜÀòÂÒÂ×

Lutz Stoeber is an experienced professional in venture capital and investment, currently serving as a Board Observer at Allay Therapeutics and Laxxon Medical, while also holding the position of Head of Venture Capital & Investments North America at Evonik Venture Capital since September 2012. Stoeber's expertise includes investments in Advanced Materials, Drug Delivery, Advanced Nutrition, and Personal Care. Additional roles include Board Observer at Element and Modern Meadow, Advisory Board Member at Union Labs Ventures, Tech Council Ventures, and Pangaea Ventures, and a prior role as Director at S&Y ACHIEVEMENT LLC. Stoeber's previous experience also includes a position as Senior Analyst and Investment Professional at PARDUS CAPITAL MANAGEMENT L.P. Educational qualifications include a post-doctorate from Imperial College London, further studies at New York University, and education at Schule Schloss Salem.